{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:09:49Z","timestamp":1793761789747,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.drugalcdep.2017.01.013","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T23:14:00Z","timestamp":1488323640000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"special_numbering":"C","title":["Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment\u2014A nation-wide register-based open cohort study"],"prefix":"10.1016","volume":"174","author":[{"given":"Tove","family":"Abrahamsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"\u00d6jehagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0005","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/08897077.2015.1065541","article-title":"Interim buprenorphine treatment in opiate dependence: a pilot effectiveness study","volume":"37","author":"Abrahamsson","year":"2015","journal-title":"Subst. Abus."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0010","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/09595230601052777","article-title":"Zopiclone misuse: an update from Dublin","volume":"26","author":"Bannan","year":"2007","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0015","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1478-7954-12-11","article-title":"Suicide or undetermined intent? A register-based study of signs of misclassification","volume":"12","author":"Bj\u00f6rkenstam","year":"2014","journal-title":"Popul. Health Metr."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0020","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.drugalcdep.2007.03.008","article-title":"Benzodiazepine prescription for patients in opioid maintenance treatment in Norway","volume":"90","author":"Bramness","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0025","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1360-0443.2009.02570.x","article-title":"Mortality among opiate users: opioid maintenance therapy, age and causes of death","volume":"104","author":"Clausen","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0030","doi-asserted-by":"publisher","first-page":"c5475","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database","volume":"341","author":"Cornish","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0035","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jsat.2011.05.001","article-title":"Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study","volume":"41","author":"Cousins","year":"2011","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0040","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/j.1360-0443.1996.tb03800.x","article-title":"Fatal heroin \u2018overdose\u2019: a review","volume":"91","author":"Darke","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0045","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","article-title":"Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study","volume":"102","author":"Davoli","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0050","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0055","doi-asserted-by":"publisher","first-page":"e59981","DOI":"10.1371\/journal.pone.0059981","article-title":"Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients","volume":"8","author":"Garassino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0060","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","article-title":"Mortality in heroin addiction: impact of methadone treatment","volume":"82","author":"Gr\u00f6nbladh","year":"1990","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0065","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s00228-013-1578-5","article-title":"Pregabalin abuse among opiate addicted patients","volume":"69","author":"Grosshans","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0070","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.04.028","article-title":"Profiles of pregabalin and gabapentin abuse by postmortem toxicology","volume":"241","author":"H\u00e4kkinen","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0075","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","article-title":"Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data","volume":"98","author":"Hajak","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0080","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/jech.56.4.301","article-title":"Comparing hospital discharge records with death certificates: can the difference be explained?","volume":"56","author":"Johansson","year":"2000","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0085","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0090","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.forsciint.2006.08.002","article-title":"Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002\u20132003","volume":"169","author":"Jonsson","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0095","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2013will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0100","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jsat.2015.04.008","article-title":"Predictors of opioid-related death during methadone therapy","volume":"57","author":"Leece","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0105","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","article-title":"Benzodiazepines, methadone and buprenorphine: interactions and clinical management","volume":"19","author":"Lintzeris","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0110","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.2174\/13816128113199990425","article-title":"The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview","volume":"19","author":"Martinotti","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0115","doi-asserted-by":"publisher","first-page":"b2225","DOI":"10.1136\/bmj.b2225","article-title":"Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study","volume":"338","author":"McCowan","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0120","series-title":"Information Fr\u00e5n L\u00e4kemedelsverket 21;3","author":"Medical Products Agency","year":"2010"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0125","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00228-015-1841-z","article-title":"Association between hypnotics use and increased mortality: causation or confounding?","volume":"71","author":"Neutel","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0130","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.drugalcdep.2014.10.021","article-title":"Excessive suicide mortality and risk factors for suicide among patients with heroin dependence","volume":"145","author":"Pan","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0135","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1472-684X-11-25","article-title":"End-of-life medical decisions in France: a death certificate follow-up survey 5 years after the 2005 act of parliament on patients' rights and end of life","volume":"11","author":"Pennec","year":"2012","journal-title":"BMC Palliat. Care"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0140","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0145","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1081\/CLT-120026520","article-title":"Comparison of the fatal toxicity index of zopiclone with benzodiazepines","volume":"41","author":"Reith","year":"2003","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-015-0037-2","article-title":"Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden","volume":"12","author":"Richert","year":"2015","journal-title":"Harm Reduct. J."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2017.01.013_bib0155","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/00023210-200418001-00004","article-title":"The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents","volume":"18","author":"Sanger","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0160","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40263-014-0164-4","article-title":"Misuse and abuse of pregabalin and gabapentin: cause for concern?","volume":"28","author":"Schifano","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0165","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.drugalcdep.2013.04.006","article-title":"Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes","volume":"132","author":"Schuman-Olivier","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0170","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1465-3362.2009.00057.x","article-title":"Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data","volume":"28","author":"Stoov\u00e9","year":"2009","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0175","series-title":"Socialstyrelsens f\u00f6reskrifter och allm\u00e4nna r\u00e5d om l\u00e4kemedelsassisterad behandling vid opiatberoende [The Board's provisions and general guidelines on medication-assisted treatment in opiate dependence]","author":"The National Board of Health and Welfare (Socialstyrelsen)","year":"2009"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0180","series-title":"Kartl\u00e4ggning av l\u00e4kemedelsassisterad behandling vid opiatberoende [Survey of medication-assisted treatment in opiate dependence]","author":"The National Board of Health and Welfare (Socialstyrelsen)","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0185","series-title":"ATC\/DDD Index 2015","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0190","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1360-0443.2001.96811135.x","article-title":"Heroin overdose: causes and consequences","volume":"96","author":"Warner-Smith","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0195","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/ajad.12159","article-title":"Prescription medication misuse among opioid dependent patients seeking inpatient detoxification","volume":"24","author":"Wilens","year":"2015","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0200","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1528-1167.2010.02966.x","article-title":"The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials","volume":"52","author":"Zaccara","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2017.01.013_bib0205","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pbb.2011.10.023","article-title":"Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers","volume":"100","author":"Zacny","year":"2012","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617300856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617300856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T19:29:24Z","timestamp":1536002964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617300856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":41,"alternative-id":["S0376871617300856"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.01.013","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment\u2014A nation-wide register-based open cohort study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}